Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
just got a second vaccine on 5/6/2025; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on 05-OCT-2023). On 06-MAY-2025, the patient received the 2nd dose of Shingrix. On 06-MAY-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: just got a second vaccine on 5/6/2025). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 16-MAY-2025 The patient self-reported this case for herself. The reporter had her first shingles vaccine on but forgot to get a second dose. The reporter just got a second vaccine. The reporter asked was the vaccine still effective or were these dosages too far apart, does she need to have another vaccine within 6 months of this last does for it to be effective. The patient received second dose of Shingrix longer than the recommended interval which led to lengthening of vaccination schedule.